This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,759.96, is for the supply of Ozempic, a medication used to treat diabetes. It is a firm fixed-price contract with an ultimate completion date of April 22, 2025. The contract is not set aside for any specific business type. This delivery order is part of a larger Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,546.47 firm fixed-price contract is for the delivery of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of November 26, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,365.20, is for the delivery of Ozempic, a medication used to treat diabetes. It is a firm fixed-price contract with an ultimate completion date of April 22, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00, which provides a comprehensive...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,461.44, is for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml, a diabetes medication. The contract is a firm fixed-price delivery order with an ultimate completion date of April 17, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,448.13 firm fixed-price contract is for the delivery of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml, a medication used to treat type 2 diabetes. The contract has a completion date of January 7, 2025 and was awarded on January 6, 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $7,680.29, is for the delivery of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml, a medication used to treat diabetes. The contract has an ultimate completion date of November 26, 2024 and is a firm fixed-price contract. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Ozempic, a diabetes medication. The contract has a firm fixed price of $2,819.97 and an ultimate completion date of April 17, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,248.34 firm fixed-price contract is for the supply of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml, a medication used to treat diabetes. The contract has an ultimate completion date of January 18, 2024 and was awarded on January 17, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that...
This is a $1,879.98 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Ozempic, a medication used to treat type 2 diabetes, with a period of performance through March 3, 2025. This delivery order contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA...
This is a $25,112.04 delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Ozempic, a specialty medication used for diabetes management. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a...